Live feed
Filing
SC 13G
SC 13G0000919574-19-004168·Broadfin Capital, LLC
Schedule 13G ownership disclosure
EIGER BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 28249U105
Event date: 2019-06-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.7800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-19-004168
- Form type
- SC 13G
- Filer
- Broadfin Capital, LLC
- CIK
- CIK 1511901
- Filed
- Jun 14, 2019
- Reporting period
- Jun 06, 2019
- Description
- Schedule 13G beneficial ownership